News

Avive Solutions, Inc. has announced it has raised an additional $7 Million in funding, bringing the total raised to over $15 Million since the Company’s inception in 2017. Focused on addressing the global public health issue of sudden cardiac...

TARA Biosystems, Inc., a company generating in vitro human biology to increase the success of cardiac disease drug discovery and development, announced a $10 million Series A2 financing. This financing will be used to scale TARA’s cardiac...

The Global Top 5 wearable brand[1], Amazfit's mother company, Huami, made its second wearable AI chip Huangshan-2 public at its first innovation conference entitled "AI to Decode the Future." Multiple hardware and a series of big data and AI...

The COVID-19 pandemic in New York City caused a surge in out-of-hospital cardiac arrests and deaths, according to a study co-authored by researchers at Albert Einstein College of Medicine, Montefiore Health System, and the Fire Department of...

Voice analysis by a smartphone app identifies lung congestion in heart failure patients, allowing early intervention before their condition deteriorates. The small study is presented on HFA Discoveries, a scientific platform of the European...

The Heart Rhythm Society's COVID-19 Rapid Response Task Force Helps Answer Call for Guidance During Pandemic WASHINGTON, D.C., June 16, 2020 – In response to the COVID-19 pandemic, the Heart Rhythm Society (HRS) led a global cross-sectional...

Proximo Medical, LLC, a business acceleration solution that addresses medical device commercialization challenges among startup and established medical device technologies looking to expand adoption in the U.S., announced a partnership...

The StopAfib.org Library, an invaluable collection of video resources for people living with atrial fibrillation (AFib), is now available at no cost. The world-renowned StopAfib.org patient advocacy organization empowers those living with...

Montreal Heart Institute First to Use New Degassed Saline During Innovative Cardiac Ablation Procedure The Montreal Heart Institute (MHI) and Thermedical®, a developer of thermal-ablation systems to treat ventricular arrhythmias, announced...

 CardioFocus, Inc. today announced that the first U.S. patients have been treated commercially with the recently-approved HeartLight® X3 Endoscopic Ablation System. The revolutionary cardiac ablation technology is designed to treat drug...